COMMUNIQUÉS West-GlobeNewswire

CytomX Therapeutics Announces CX-072 Clinical Presentations at 2018 SITC Annual Meeting
06/11/2018
PROCLAIM-CX-072 Clinical Translational Data Presented as Poster and Rapid-Fire Oral Presentation Company to Host Analyst and Investor Event and Webcast SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- [...]
Auransa to Participate in BioCentury-BayHelix China Healthcare Summit 2018
06/11/2018
PALO ALTO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Auransa, Inc., an artificial intelligence (AI)-driven pharmaceutical company developing precision medicines in areas of significant unmet medical need, today [...]
Bethesda Sedation Dentistry Upgrades to New, State-of-the-Art Office
06/11/2018
The dental practice of Deborah Klotz, DDS and Robert Schlossberg, DDS has moved locations in Bethesda, offering an expanded office space and new technology. BETHESDA, Md., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Dr. Deborah [...]
Sorrento Therapeutics Anti-CEA CAR-T Demonstrates Significant Therapeutic Activity With Increased Overall Survival in Pancreatic Cancer Patients With Liver Metastases
06/11/2018
Two out of four patients showed complete resolution of liver metastases on PET scan Median overall survival (OS) 8.3 months and mean OS 9.8 months, compared to the standard of care 3 to 6 months Meeting scheduled with [...]
Immune Design Announces Multiple G100 Presentations at the Society for Immunotherapy of Cancer Meeting (SITC) Annual Meeting
06/11/2018
New data further support G100’s broad potential in hematological malignancies and solid tumors SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), an immunotherapy [...]
Unum Therapeutics to Present Preclinical Data on a New, Emerging Platform Technology for Solid Tumors at the SITC Annual Meeting
06/11/2018
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), today announced that the Company will present preclinical data on a new proprietary technology platform called B olt- O n Chi [...]
East Kent Hospitals goes live with Allscripts PAS
06/11/2018
Another NHS trust in Kent takes the first step on its electronic patient record journey CHICAGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- East Kent Hospitals University NHS Foundation Trust has gone live with the Allscripts [...]
EDAP TMS SA : EDAP TMS SA to Announce Third Quarter 2018 Financial Results on Wednesday, November 14
06/11/2018
LYON, France, November 6, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter and nine months ended September [...]
Jounce Therapeutics to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 13, 2018
06/11/2018
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
Distinguished Physicians Join Biotricity’s Newly Formed Scientific and Medical Alliance Board
06/11/2018
Experts to Help Drive Improvements in Technology and Support the Development of New Solutions REDWOOD CITY, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY ), a medical diagnostic and consumer [...]
GBT Announces New Employment Inducement Grants
06/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT or the Company) (NASDAQ: GBT) today announced that, on November 1, 2018, the compensation committee of the Company’s [...]
SciCann Therapeutics Announces Positive ISA Report for “Steady Stomach” CBD Combination Therapy Patent
06/11/2018
TORONTO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- SciCann Therapeutics Inc. (“ SciCann ”) announced today it has received a positive International Search Authority (ISA) report from the Patent Cooperation Treaty (PCT) for its [...]
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
06/11/2018
WALTHAM, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the following investor conferences: Jefferies London Healthcare [...]
ContraVir Pharmaceuticals to Present Two Posters at The Liver Meeting® 2018, Hosted by the American Association for the Study of Liver Diseases
06/11/2018
EDISON, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of liver [...]
Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Proprietary Tele-Pharmacy Platform
06/11/2018
MIAMI, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top [...]
Daré to Host Third Quarter 2018 Financial Results Conference Call and Webcast
06/11/2018
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that it will host a conference call and live webcast at 8:30 a.m. [...]
Aeterna Zentaris Settles Dispute with Cogas Consulting, LLC
06/11/2018
CHARLESTON, S.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) and Cogas Consulting, LLC have amicably resolved their dispute with Aeterna Zentaris Inc. agreeing to make a payment to [...]
Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
06/11/2018
38% Objective Response Rate (ORR) demonstrated in 47 Metastatic Melanoma patients who were unsuccessfully treated with a prior PD-1 blocking antibody Median Duration of Response (DOR) of 6.4 Months Data selected for [...]
Transactions in relation to share buyback program
06/11/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Pages